BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31049278)

  • 21. Recent advances in using folate receptor 1 (FOLR1) for cancer diagnosis and treatment, with an emphasis on cancers that affect women.
    Varaganti P; Buddolla V; Lakshmi BA; Kim YJ
    Life Sci; 2023 Aug; 326():121802. PubMed ID: 37244363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engrailed-2 (EN2) - a novel biomarker in epithelial ovarian cancer.
    McGrath SE; Annels N; Madhuri TK; Tailor A; Butler-Manuel SA; Morgan R; Pandha H; Michael A
    BMC Cancer; 2018 Oct; 18(1):943. PubMed ID: 30285763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical associations between ASCT2 and p‑mTOR in the pathogenesis and prognosis of epithelial ovarian cancer.
    Guo H; Xu Y; Wang F; Shen Z; Tuo X; Qian H; Wang H; Wang K
    Oncol Rep; 2018 Dec; 40(6):3725-3733. PubMed ID: 30272366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Folate receptor-α (FOLR1) expression and function in triple negative tumors.
    Necela BM; Crozier JA; Andorfer CA; Lewis-Tuffin L; Kachergus JM; Geiger XJ; Kalari KR; Serie DJ; Sun Z; Moreno-Aspitia A; O'Shannessy DJ; Maltzman JD; McCullough AE; Pockaj BA; Cunliffe HE; Ballman KV; Thompson EA; Perez EA
    PLoS One; 2015; 10(3):e0122209. PubMed ID: 25816016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of folate receptors alpha and beta in normal and cancerous gynecologic tissues: correlation of expression of the beta isoform with macrophage markers.
    O'Shannessy DJ; Somers EB; Wang LC; Wang H; Hsu R
    J Ovarian Res; 2015 May; 8():29. PubMed ID: 25971554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Folic-acid metabolism and DNA-repair phenotypes differ between neuroendocrine lung tumors and associate with aggressive subtypes, therapy resistance and outcome.
    Walter RF; Mairinger FD; Werner R; Vollbrecht C; Hager T; Schmid KW; Wohlschlaeger J; Christoph DC
    Oncotarget; 2016 Apr; 7(15):20166-79. PubMed ID: 27064343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential expression of folate receptor 1 in medulloblastoma and the correlation with clinicopathological characters and target therapeutic potential.
    Liu H; Sun Q; Zhang M; Zhang Z; Fan X; Yuan H; Li C; Guo Y; Ning W; Sun Y; Song Y; Yu C
    Oncotarget; 2017 Apr; 8(14):23048-23060. PubMed ID: 28416738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphism in one-carbon metabolism pathway affects survival of gastric cancer patients: Large and comprehensive study.
    Zhao T; Gu D; Xu Z; Huo X; Shen L; Wang C; Tang Y; Wu P; He J; Gong W; He ML; Chen J
    Oncotarget; 2015 Apr; 6(11):9564-76. PubMed ID: 25840420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: the association with treatment efficacy of pemetrexed.
    Chen CY; Chang YL; Shih JY; Lin JW; Chen KY; Yang CH; Yu CJ; Yang PC
    Lung Cancer; 2011 Oct; 74(1):132-8. PubMed ID: 21367480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance of blood and salivary IEX-1 expression in diagnosis of epithelial ovarian carcinoma.
    Li Y; Tan C; Liu L; Han L
    J Obstet Gynaecol Res; 2018 Apr; 44(4):764-771. PubMed ID: 29431239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validity and prognostic significance of sperm protein 17 as a tumor biomarker for epithelial ovarian cancer: a retrospective study.
    Brunette LL; Mhawech-Fauceglia PY; Ji L; Skeate JG; Brand HE; Lawrenson K; Walia S; Chiriva-Internati M; Groshen S; Roman LD; Kast WM; Da Silva DM
    BMC Cancer; 2018 Oct; 18(1):970. PubMed ID: 30309325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Importance of gene variants and co-factors of folate metabolic pathway in the etiology of idiopathic intellectual disability.
    Dutta S; Shaw J; Chatterjee A; Sarkar K; Usha R; Chatterjee A; Sinha S; Mukhopadhyay K
    Nutr Neurosci; 2011 Sep; 14(5):202-9. PubMed ID: 22005284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HPIP expression predicts chemoresistance and poor clinical outcomes in patients with epithelial ovarian cancer.
    Wang Y; Li M; Meng F; Lou G
    Hum Pathol; 2017 Feb; 60():114-120. PubMed ID: 27818289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of GPNMB predicts an unfavorable outcome of epithelial ovarian cancer.
    Ma RQ; Tang ZJ; Ye X; Cheng HY; Sun KK; Chang XH; Cui H
    Arch Gynecol Obstet; 2018 May; 297(5):1235-1244. PubMed ID: 29428978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer.
    Li T; Xue H; Guo Y; Guo K
    Oncol Rep; 2014 Apr; 31(4):1825-31. PubMed ID: 24573179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The conglomeration of diagnostic, prognostic and therapeutic potential of serum miR-199a and its association with clinicopathological features in epithelial ovarian cancer.
    Zuberi M; Khan I; Gandhi G; Ray PC; Saxena A
    Tumour Biol; 2016 Aug; 37(8):11259-66. PubMed ID: 26951510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of folate receptor 1 in paclitaxel-resistance of nasopharyngeal carcinoma cells].
    Li W; Tan GL; Ma YH; Peng XW; He GX
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Dec; 45(12):1035-40. PubMed ID: 21215055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Folate-mediated one-carbon metabolism genes and interactions with nutritional factors on colorectal cancer risk: Women's Health Initiative Observational Study.
    Cheng TY; Makar KW; Neuhouser ML; Miller JW; Song X; Brown EC; Beresford SA; Zheng Y; Poole EM; Galbraith RL; Duggan DJ; Habermann N; Bailey LB; Maneval DR; Caudill MA; Toriola AT; Green R; Ulrich CM
    Cancer; 2015 Oct; 121(20):3684-91. PubMed ID: 26108676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunotherapy targeting folate receptor induces cell death associated with autophagy in ovarian cancer.
    Wen Y; Graybill WS; Previs RA; Hu W; Ivan C; Mangala LS; Zand B; Nick AM; Jennings NB; Dalton HJ; Sehgal V; Ram P; Lee JS; Vivas-Mejia PE; Coleman RL; Sood AK
    Clin Cancer Res; 2015 Jan; 21(2):448-59. PubMed ID: 25416196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Homocysteine plasma levels in patients treated with antiepileptic drugs depend on folate and vitamin B12 serum levels, but not on genetic variants of homocysteine metabolism.
    Semmler A; Moskau-Hartmann S; Stoffel-Wagner B; Elger C; Linnebank M
    Clin Chem Lab Med; 2013 Mar; 51(3):665-9. PubMed ID: 23382314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.